Skip to content

Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and Allergy

Health2006 - an Observational Population-based Study of Cardiovascular Disease, Type 2 Diabetes, Asthma and Allergy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00316667
Enrollment
3471
Registered
2006-04-21
Start date
2006-06-30
Completion date
2008-06-30
Last updated
2012-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Cardiovascular Disease, Hypersensitivity, Osteoporosis, Type 2 Diabetes

Keywords

epidemiology, risk factors

Brief summary

The aim is to assess the population prevalence of risk factors for different chronic diseases such as cardiovascular disease, type 2 diabetes, osteoporosis, asthma, and allergy. Risk factors include genetic and serologic biomarkers, questionnaire data on health and lifestyle. There are many hypotheses under study for each research field.

Detailed description

A population-based random sample of persons living in Copenhagen is drawn from the Danish Civil Registration System and invited for a health examination including blood sample drawing, measurement of lung function, serologic and genetic biomarkers, questionnaires on lifestyle and health. The study will form the basis for research within many different areas such as cardiovascular disease, type 2 diabetes, asthma, and allergy.

Interventions

None listed

Sponsors

Steno Diabetes Center Copenhagen
CollaboratorOTHER
Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Persons living in 11 municipalities in Copenhagen

Exclusion criteria

* Pregnancy * Non-Danish citizenship

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026